B Cell Activating Factor Induces Drug Resistance in Hairy Cell Leukemia Variant

B Cell Activating Factor Induces Drug Resistance in Hairy Cell Leukemia Variant

<b>Background:</b> Chemoresistance is an existing challenge faced in the treatment of the hairy cell leukemia variant (HCL-v). Classical hairy cell leukemia (HCL-c) is very sensitive to the standard of care with purine nucleoside analogs (PNAs) cladribine (cDa) and pentostatin. However,...

Full description

Saved in:
Bibliographic Details
Main Authors: Claire Fritz, Daniel Feinberg, Akshaya Radhakrishnan, Kayla Klatt, E. Ricky Chan, Philip Rock, Richard Burack, Reshmi Parameswaran
Format: Article
Language:English
Published: MDPI AG 2025-04-01
Series:Biomedicines
Subjects:
hairy cell leukemia
chemoresistance
BAFF
HCL
Leukemia
chemo-protection
Online Access:https://www.mdpi.com/2227-9059/13/4/890
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/2227-9059/13/4/890

Similar Items